Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Vaping 1 Tobacco Use Disorder 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 Advanced Solid Tumor 1

Interventions

pembrolizumab 45 Paclitaxel 42 Carboplatin 34 Bevacizumab 18 Specimen Handling 17 Letrozole 16 lenvatinib 13 Magnetic Resonance Spectroscopy 12 dostarlimab 11 Cisplatin 11 Biopsy 11 Taxes 10 olaparib 9 Fulvestrant 9 Doxorubicin 9 abemaciclib 8 Megestrol Acetate 8 Docetaxel 8 durvalumab 7 atezolizumab 7 Nivolumab 7 Gemcitabine 7 Blood Specimen Collection 7 palbociclib 6 Oxaliplatin 6 Observation 6 Fluorouracil 6 niraparib 5 Surveys and Questionnaires 5 Progestins 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × BID protein, human × 1 year × Clear all

NCT06712472 2026-01-20

RAINBO-RED

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡